RITUXAN (rituximab)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+10
GENENTECH
Indication
Granulomatosis with polyangiitis
Granulomatosis with polyangiitis is a rare, systemic autoimmune disease classified within the spectrum of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides. Read more about Granulomatosis with polyangiitis
5 drugs 5 manufacturers
Drugs that treat it
Common Granulomatosis with polyangiitis therapies.
TRUXIMA (rituximab-abbs)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+7
CEPHALON,INC.
RUXIENCE (rituximab-pvvr)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+7
Parke-Davis Pfizer
RIABNI (rituximab-arrx)
ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+9
AMGEN
TAVNEOS (avacopan)
COMPLEMENT INHIBITORS·GRANULOMATOSIS WITH POLYANGIITIS·+1
CHEMOCENTRYX/AM
Filter & compare in the drug finder →Opens the drug finder with Granulomatosis with polyangiitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGranulomatosis with polyangiitis is a rare, systemic autoimmune disease classified within the spectrum of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides.
It predominantly affects adults, although it can manifest at any age, and characteristically targets the upper and lower respiratory tracts along with the kidneys.
Pathophysiologically, the condition is defined by necrotizing granulomatous inflammation of tissue and necrotizing vasculitis of small- to medium-sized blood vessels.
Common clinical manifestations include chronic destructive rhinosinusitis, pulmonary nodules or cavitary lesions, and rapidly progressive, pauci-immune crescentic glomerulonephritis.
- nih.gov
Granulomatosis with polyangiitis is a rare, systemic autoimmune disease classified within the spectrum of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides Pathophysiologically, the condition is defined by necrotizing granulomatous inflammation of tissue and necrotizing vasculitis of small- to medium-sized blood vessels
- nih.gov
It predominantly affects adults, although it can manifest at any age, and characteristically targets the upper and lower respiratory tracts along with the kidneys Common clinical manifestations include chronic destructive rhinosinusitis, pulmonary nodules or cavitary lesions, and rapidly progressive, pauci-immune crescentic glomerulonephritis
- medlineplus.gov
It predominantly affects adults, although it can manifest at any age, and characteristically targets the upper and lower respiratory tracts along with the kidneys
- nih.gov
Pathophysiologically, the condition is defined by necrotizing granulomatous inflammation of tissue and necrotizing vasculitis of small- to medium-sized blood vessels
- clevelandclinic.org
Common clinical manifestations include chronic destructive rhinosinusitis, pulmonary nodules or cavitary lesions, and rapidly progressive, pauci-immune crescentic glomerulonephritis
Personalize your experience
Follow Granulomatosis with polyangiitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.